Valuation: Boule Diagnostics AB

Market Cap 4.95Cr 48.47L 44.15L 40.68L 37L 69.42L 45Cr 72.96L 1.97Cr 25Cr 1.82Cr 1.78Cr 77Cr P/E 2026 *
-5.07x
P/E 2027 * 5.76x
Enterprise Value 25Cr 2.41Cr 2.19Cr 2.02Cr 1.84Cr 3.45Cr 223.07Cr 3.63Cr 9.78Cr 121.84Cr 9.04Cr 8.85Cr 382.38Cr EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.48x
Free-Float
64.69%
Yield 2026 *
-
Yield 2027 * -
1 day+3.24%
1 week-8.27%
Current month+23.19%
1 month-38.70%
3 months-61.48%
6 months-61.13%
Current year-74.03%
1 week 1.14
Extreme 1.145
1.34
1 month 0.84
Extreme 0.84
2.13
Current year 0.84
Extreme 0.84
5.68
1 year 0.84
Extreme 0.84
6.26
3 years 0.84
Extreme 0.84
12.62
5 years 0.84
Extreme 0.84
59.5
10 years 0.84
Extreme 0.84
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+3.24%-8.27%-76.82%-87.02% 47.04L
-2.79%-4.27%+16.69%+43.55% 26TCr
-3.16%-5.08%-0.92%+6.05% 16TCr
-2.01%-9.28%-29.33%+30.72% 14TCr
-2.35%-5.02%-56.73%-22.75% 6.23TCr
-1.95%-3.73%+18.40%+52.24% 5.97TCr
-1.96%-1.92%+3.84%-14.15% 5.35TCr
-2.83%-1.52%+17.99%+50.58% 4.94TCr
-3.51%-4.71%+17.06%+68.19% 4.49TCr
+1.26%-11.97%-2.48%+50.80% 4.26TCr
Average -1.71%-4.09%-9.23%+17.82% 9TCr
Weighted average by Cap. -2.49%-3.60%-0.82%+28.87%

Financials

2026 *2027 *
Net sales 45Cr 4.44Cr 4.04Cr 3.72Cr 3.39Cr 6.35Cr 410.79Cr 6.68Cr 18Cr 224.37Cr 17Cr 16Cr 704.17Cr 48Cr 4.73Cr 4.31Cr 3.97Cr 3.61Cr 6.78Cr 438.17Cr 7.12Cr 19Cr 239.33Cr 18Cr 17Cr 751.1Cr
Net income -97.73L -10L -9L -8L -7L -13.7L -8.86Cr -14.4L -38.84L -4.84Cr -35.9L -35.14L -15Cr 85.96L 8L 8L 7L 6L 12.05L 7.79Cr 12.67L 34.17L 4.26Cr 31.58L 30.91L 13Cr
Net Debt 20Cr 1.92Cr 1.75Cr 1.61Cr 1.47Cr 2.76Cr 178.18Cr 2.9Cr 7.81Cr 97Cr 7.22Cr 7.07Cr 305.44Cr 18Cr 1.81Cr 1.65Cr 1.52Cr 1.38Cr 2.59Cr 167.28Cr 2.72Cr 7.33Cr 91Cr 6.78Cr 6.63Cr 286.74Cr
Projected Income Statement - Annual - Boule Diagnostics AB
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
20/26/20 SEK 1.275 +3.24% 2,31,052
19/26/19 SEK 1.235 +2.49% 1,13,990
18/26/18 SEK 1.205 -5.49% 4,72,336
17/26/17 SEK 1.275 0.00% 74,948
16/26/16 SEK 1.275 +2.41% 5,89,621
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.275SEK
Average target price
3.800SEK
Spread / Average Target
+198.04%
  1. Stock Market
  2. Stocks
  3. BOUL Stock